Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Times Denmark.
GenAI in MedTech Market Trends, Applications and Growth Opportunities
Ottawa, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The global GenAI in the medtech market is driven by the expansion of its healthcare applications, growing innovations, increasing R&D activities, and growing diseases. GenAI streamlines workflows,...
Superfoods Market Size to Capture USD 288.82 Billion by 2034, Driven by Increasing Health Awareness and Demand for Functional Foods
Ottawa, May 06, 2025 (GLOBE NEWSWIRE) -- The global superfoods market size was reached at USD 193.25 billion in 2024 and is projected to grow from USD 201.17 billion in 2025 to nearly USD 288.82 billion by 2034, registering a compound annual...
ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other...
Minister Dion George concludes South Africa’s participation at Copenhagen Climate Ministerial
Minister George concludes South Africa’s participation at Copenhagen Climate Ministerial Minister Dion George, South Africa’s Minister of Forestry, Fisheries and the Environment, has concluded an impactful participation at the Copenhagen Climate...
ISS renews and expands public healthcare agreement in Southeast Asia
Copenhagen , May 05, 2025 (GLOBE NEWSWIRE) -- Under the agreement, ISS will deliver services across a range of healthcare institutions. It has a five-year duration, with an option to extend. Carl-Fredrik Bjor, Group Chief Commercial & Revenue...
Ascendis Pharma Reports First Quarter 2025 Financial Results
- Q1 2025 revenue of €44.7 million for YORVIPATH® and €51.3 million for SKYTROFA® - TransCon™ CNP NDA submitted in Q1 2025; MAA submission planned in Q3 2025 - Topline COACH combination trial (TransCon CNP + TransCon hGH) data expected in Q2 2025...
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a...
Minister Dion George represents South Africa at Copenhagen Climate Ministerial in Denmark, 7 to 8 May
Dr Dion George, South Africa’s Minister of Forestry, Fisheries and the Environment, will represent the nation at the Copenhagen Climate Ministerial in Denmark on 7-8 May 2025, a critical platform leading to COP30 in Belém, Brazil. This global...
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
Press release – No. 6 / 2025 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes The Phase 2b ZUPREME-2 trial investigates the efficacy and safety...
Single-Cell Biotherapeutics Market: Trends, Growth Drivers and Regional Insights (2025–2034)
Ottawa, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The global single-cell biotherapeutics market is experiencing robust growth and is expected to reach hundreds of millions in revenue between 2025 and 2034. This expansion is driven by shifting consumer...
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics,...
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2025 financial results and provide a business update on Thursday, May 1, 2025, after the close of the U.S....
Antag Therapeutics expands senior team to support clinical progress
Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity, today announces the appointment of three new hires to support the Company’s next phase of...
Herbal Medicine Market Size to Achieve USD 580.81 Billion by 2034, Rising demand for natural treatments drives market growth
Ottawa, April 29, 2025 (GLOBE NEWSWIRE) -- The global herbal medicine market size stood at USD 87.05 billion in 2024 and is forecast to grow around USD 580.81 billion by 2034, increasing from USD 105.24 billion in 2025, expanding at a CAGR of...
Butyric Acid Market Size Worth USD 634.55 Million by 2034 Driven by Rising Demand Across Animal Feed and Pharmaceutical Industries
Ottawa, May 05, 2025 (GLOBE NEWSWIRE) -- The global butyric acid market size has been calculated at USD 422.13 million in 2025 and is estimated to rise from USD 440.28 million in 2026 to USD 634.55 million by 2034. The large application of butyric...
After Norway, What’s Next? The Kingdom of Denmark and the Arctic Council’s Future
Back to Publications Sermitsiaq (Saddle) Mountain forms a backdrop for Nuuk, capital of Greenland. Photo: David Stanley On May 12, 2025, at the 14th ministerial meeting of the Arctic Council, Norway will officially conclude its Arctic Council...
Food Fortifying Agents Market Size to Hit USD 242.2 Billion by 2034, Rising Consumer Awareness About the Importance of Nutrition
Ottawa, April 30, 2025 (GLOBE NEWSWIRE) -- The global food fortifying agents market size was accounted for USD 100.45 billion in 2024 and is projected to grow from USD 109.69 billion in 2025 to nearly USD 242.20 billion by 2034, registering a...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; October 14,...
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
Press release – No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of...
Bioprocess Bags Market Surges to USD 18.65 Billion by 2034 at 16.44% CAGR, Reports Towards Healthcare
Ottawa, April 29, 2025 (GLOBE NEWSWIRE) -- The global bioprocess bags market size was valued at USD 4.07 billion in 2024 and is predicted to hit around USD 18.65 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence...